UFC names NinjaTrader as official futures trading partner

UFC has announced NinjaTrader, a Payward company, as its official futures trading partner in the United States and Canada through a multiyear agreement. The partnership provides NinjaTrader with brand visibility across UFC's platform, which reaches more than 700 million fans across 210 countries and territories.

Under the agreement, NinjaTrader becomes the presenting partner of Dana White's Contender Series and official partner of UFC Freedom 250, scheduled for June 14 at the White House in Washington, D.C. The company's branding will appear in the Octagon and across broadcasts reaching an estimated 1 billion households globally.

"UFC fans understand discipline, preparation, and the pressure of performing in moments that matter, which makes NinjaTrader a perfect partner for UFC," said Nicholas Smith, Senior Vice President of Global Partnerships at TKO Group Holdings (NYSE: TKO), UFC's parent company.

NinjaTrader, which has operated since 2003, provides futures trading technology to over 3.5 million traders. The company offers a cloud-based platform available on desktop, web, and mobile devices. Parent company Payward operates across cryptocurrency, futures, derivatives, payments, and tokenized equities.

"Payward is building open, global rails for financial markets," said Arjun Sethi, Co-CEO of Payward. "Anyone with an internet connection should have access to the same markets, on the same terms, as anyone else."

As presenting partner of Dana White's Contender Series, NinjaTrader becomes the exclusive official fight kit partner, with branding on fight kits and walkout gear worn by athletes and their corner teams. The partnership will include trading competitions, educational experiences, and opportunities for fans to trade alongside professional traders.

The information is based on a company press release statement.

You May Also Be Interested In

• FTI Consulting names Jerome Nyssen senior managing director in Australia
• Taysha Gene Therapies (TSHA) PT Raised to $11 at Citizens on REVEAL Data Update
• EU approves AbbVie's Skyrizi for children with plaque psoriasis